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Background: The “proximal-type” epithelioid sarcoma is a very rare kind of mesenchimal tumor characterized by
the difficulty in histological diagnosis and the very aggressive biological behavior.
Case: We report of a case of a 63 years old woman with a vulvar “proximal-type” epithelioid sarcoma that
underwent a radical surgical staging followed by an adjuvant radiotherapy. She is on follow-up care for 14 months
and there is no clinical evidence of disease.
Conclusion: Even if quite rare the proximal type epithelioid sarcoma should be regarded as a separate entity of
particularly aggressive biologic behaviour. Its diagnosis attracts controversies and criticism related to the surgical
approach and the choice of an adjuvant therapy.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1508554852942125
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Among vulvar malignancies sarcomas are mainly uncom-
mon diagnoses, in fact most of the vulvar neoplasms are
represented by squamous cells carcinoma. Considering
the total amount of vulvar sarcoma (1.5-5% of all vulvar
neoplasia) the most common type is leiomyosarcoma,
contrary the epithelioid sarcoma is so unfrequent that
its diagnosis could not be reached. On the other hand
if the “classical-type” epithelioid sarcoma is often indo-
lent the “proximal-type” is a very aggressive neoplasm
with a natural inclination to start spreading in the or-
ganism [1]. The dynamics of evolution of this tumor
and its best treatment have not been totally defined.
We report a case of vulvar “proximal-type” ephitelioid
sarcoma accompanied by regional lymph node meta-
static repetitions in a 63 old woman.* Correspondence: giacomo.corrado@alice.it
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In January 2012 a 63 year-old woman presented to the
Department of Obstetrics and Gynecology of “Tor
Vergata” University of Rome because of a pruritic vulvar
plaque with irregular margins appeared three months
before in the vulvar paraclitoral commissure area. Her
family history did not reveal malignancies in first-degree
relatives and her past medical history was unremarkable.
She was 2 gravida 2 para and referred no previous
gynecological pathologies. At gynecological examination
vagina, cervix and uterus appeared normal, on the
contrary a vulvar indurated and ulcerated lesion was ob-
served (maximum diameter = 4 cm). The mass involved
the clitoris and both the right and left majus and minus
labium. Two excisional biopsies were taken from the pri-
mary lesion that documented a VIN3. Extended second
biopsy was needed for the quickly increase of the plaque.
Histological evaluation revealed nodules of neoplastic
cells with the features of severe anaplasia. Immunohisto-
chemistry the tumor was positive for vimentin, focal posi-
tivity with AE1-AE3 CK, CK5 and high molecular weight
cytokeratin and negative for EMA, CD34, desmin, myosin,
CroA, synaptophysin and S100. It was defined a proximal-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A) Histologically the tumor was composed of nodules
of polygonal epithelioid and spindle cells circumscribe areas of
central hyalinization and necrosis (H&E, ×200). B) The nodular
pattern was composed by large cells with amphophilic cytoplasm.
The tumor nodules were surrounded by and infiltrated by
inflammatory cells. Nuclei were large and vescicolar and nucleoli
were overshot (H&E, ×200). C) Immunostaining showed KERAE1-
AE3+, VIM+, EMA-, CD34- ker 5-6-, s100-, ACTml-, MART1-, HMB45-
(H&E, ×200).
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sarcoma. The initial diagnosis was successively confirmed
by another external pathologist. Surgical margins were
positive. The patient was prior submitted to a total body
CT scan that did not reveal distant metastasis and a week
after the diagnosis she underwent radical vulvectomy and
bilateral inguinal lymph node dissection by Micheletti’s
classic surgical technique [2]. The pathologist diagnosis
confirmed a proximal-type ephitelioid sarcoma of the
vulva.
Histologically the tumor was composed of nodules of
polygonal epithelioid and spindle cells circumscribe
areas of central hyalinization and necrosis (Figure 1A).
The nodular pattern was composed by large cells with
amphophilic cytoplasm. The tumor nodules were
surrounded and infiltrated by inflammatory cells. Nuclei
were large and vescicolar and nucleoli were overshot
(Figure 1B). Immunohistochemistry the tumor was posi-
tive for vimentin, smooth muscle actin and Ki-67; focal
positivity with AE1-AE3 CK, CK5 and high molecular
weight cytokeratin and negative for EMA, CD34, desmin,
myosin, CroA, synaptophysin and S100 (Figure 1C).
The surgical margins were free of neoplasm. One of
35 inguinal lymph nodes was metastatic. Following sur-
gical treatment, adjuvant radiotherapy was planned.
Nowadays at a 14 months-follow-up the patients is free
of disease.
Conclusions
Epithelioid sarcoma was first described by Enzinger in
1970 [3]. It is a rare soft-tissue sarcoma typically present-
ing as a subcutaneous or deep dermal mass and originat-
ing in distal and proximal extremities of adolescents and
young adults. Typically it shows a rapid clinical evolution
and tents to spread to the body in particular to the re-
gional lymph nodes, to the lung and in the abdomen. Two
different categories of epithelioid sarcoma are described in
literature: in contrast to the more common “distal-type”,
the “proximal-type” appears to be more aggressive even
if it is very rare. Epithelioid sarcoma of the vulva was
first defined by Piver et al. in 1972 [4]. It often occurs in
the labia majora of young women, and frequently could
be misdiagnosed as benign lesion such as infectious
granuloma, Bartholin's cysts, fibroma, lipoma, dermoid
cysts, fibrous histiocytoma, viral warts, or squamous cell
carcinoma [5].
PES of the vulva is an extremely rare tumor, and a re-
view of the English-language literature shows 29 cases
from 1972 to 2012 [4-27], most of these papers are case
reports and no extended clinical records are published by
now (Table 1). Majority of the patients included in the
papers were early post-menopausal women at the time of
diagnosis but some of them were very young (median age
36,4 years). All of them recounted a clinical history of atender little mass appeared in the labia majora, rapidly
growing, without symptoms or only accompanied with a
lasting itch. Frequently histological diagnosis was missed
at first and the patients typical experience was that of
repeated biopsies before definitive treatment. Literature
review showed that 19 patients underwent local excision
Table 1 Vulvar proximal type epithelioid sarcoma: the current literature review




Piver SM et al. [4] 1972 1 27 Wide local excision No No None - NED (108)
Gallup DG et al. [6] 1976 1 31 Radical vulvectomy No No None - NED (16)
Hall DJ et al. [7] 1980 1 31 Wide local excision, inguinal
lymph node dissection
No No Local, lymph node, lung 35 DOD (70)
Ulbright TM
et al. [8]
1983 2 55 Local excision No No Local, lung, abdominal wall, skin 8 DOD (15)
30 Wide local excision No Yes Local, Lung 2 DOD (8)
Tan GWT et al. [9] 1989 1 21 Wide local excision No No None - NED (36)
Perrone T et al. [10] 1989 1 21 Local excision, lymph node
dissection
No No None - NED (56)
Wevers AC et al. [11] 1989 1 21 Local excision, lymph node
dissection
No No Local recurrence 2 DOD (5)
Weissmann D
et al. [12]





1995 1 51 Radical vulvectomy No No Lung 5 DOD (8)
Konefka T et al. [14] 1994 1 49 Radical vulvectomy and bilateral
inguinal lymph node dissection
No Yes Lung 5 DOD (8)
Guillou L et al. [15] 1997 3 57 Local excision Yes No None - DOID (52)
49 Radical vulvectomy Yes No None - NED (22)
45 Wide local excision No Yes None - NED (21)
Tjalma WA et al. [16] 1999 1 23 Hemivulvectomy No No None - NED (48)
Kasamatsu T
et al. [17]
2001 1 23 Local excision No No Local lymph node 96 NED
2001 3 37 Local excision No Yes None - NED (11)
30 Local excision No No Local lymph node, skin 96 NED (104)
80 Wide local excision No No Local lymph node, lung 16 DOD (23)
Altundag K et al. [5] 2004 1 51 Left hemivulvectomy with bilateral
inguinal lymph node dissection
No Yes Lung 4 DOD (6)
Dainese E et al. [19] 2005 1 34 Right emivulvectomy with right
inguinal lymph node dissection
No No None - NED (12)
Argenta PA
et al. [20]
2007 1 35 Radical excision, inguinal-femoral
lymph node dissection
Yes No None - NED (40)
Kim JH et al. [21] 2008 1 24 Clitoris sparing wide local excision No No None - NED (8)
Rai H et al. [22] 2009 1 17 Local excision, lymph node
dissection
Yes No Local lymphnode 2 AWD (2)
Tholpady A
et al. [23]
2010 1 17 Radical excision No No - - NED (12)
Chiyoda T et al. [24] 2011 1 33 Left radical vulvectomy No No None - NED (36)
Andrisani A
et al. [25]
2011 1 46 Radical superior vulvectomy Yes Yes Local lymph nodes, abdominal wall,
genital, inguinal and thigh muscles,
bladder
1 DOD (11)
Kim HJ et al. [26] 2012 1 41 Local excision No No None - NED (10)
Ong AC et al. [27] 2012 1 51 Right emivulvectomy and right
inguinal lymph node dissection
No No None - NED (8)
Our study 1 63 Bilateral radical vulvectomy, right
inguinal lymph node dissection
Yes No Inguinal lymph node - NED (14)
NED no evidence of disease, DOD dead of disease, DOID dead of inter current disease, AWD alive with disease, RT radiotherapy, CT chemotherapy, DFS disease
free survival, OS overall survival.
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bilateral vulvectomy, 5 hemivulvectomy, in 9 cases mono
or bilateral inguinal lymph node dissection was chosen.
Among the group submitted to radical surgery (5 mono
e 5 bilateral vulvectomy) median over all survival (OS)
was 17.7 months (range 8–48 months), median disease
free survival (DFS) was 15.7 months (range 1–48 months),
4 patients died of disease (DOD) with lung, local lymph
nodes, abdominal wall, genital, inguinal, thigh muscles
and bladder metastasis within a median of 8 months after
surgery (range 6–11 months).
Among the group submitted to local excision (19
patients) median OS was 39.7 months (range 2–108
months), median DFS was 32.8 months (range 2–96
months). Five patients DOD within a median of 24.2
months after surgery (range 5–70 months), a patient
was alive with disease (AWD) 78 months after surgery
and a patient died of inter current disease 52 months
after surgery.
Ten patients were submitted to inguinal lymph node
dissection at the time of the first surgery (5 together
with radical surgery and 5 with local excision), 5 DOD
after a median of 19,4 months (range 5–56 months), two
are alive with no evidence of disease after a median of
19 months (range 12–56 months) and a patient is AWD
at a 2 months follow-up.
Only for 10 patients of the entire review adjuvant ther-
apy was indicated, 5 of them received radiotherapy and
6 chemiotherapy. Among this group 4 patients DOD
(median OS 8.25 months, median DFS 3 months), a
patient died of inter current disease after 52 months, 4
patients are alive with no evidence of disease (median
OS 23.5 months) and a patient is alive with local lymph
node metastasis after 2 months follow-up. As concerned
the tendency to spread lung, skin and local lymph node
were preferred target sites for metastasis. 12 patients
have a metastatic disease and the median time to relapse
was 23,6 months after surgery (range 1–96 months).
From the data reported in the literature there is no
treatment of choice universally approved for vulvar epi-
thelioid sarcoma. Approximately 70-77% of patients have
local recurrence [8]. That’s why immediately local exci-
sion is considered mandatory. Local wide excision or
radical vulvectomy is usually performed including 2 cm
from the margin of tumor. There is no evidence of the
beneficial effect of lymph node resection on local or dis-
tant relapse rate and inguinal lymph node dissection
should be consider only when they are clinically suspi-
cious or enlarged. The roles of adjuvant radiotherapy
and chemotherapy are not proved. Any benefit of radio-
therapy and/or chemotherapy in preventing recurrence
or for palliation has not been demonstrated. When
surgery and radiotherapy are combined a local better
control can be achieved but 40-60% of patients withhigh-grade sarcomas will die of metastatic disease. For
this reason the early detection of disease is crucial.
Ulutin et al. [1] and DiSaia et al. [28] reported a median
time of 6 months for the diagnosis of vulvar sarcoma. A
classic clinical behaviour consists in a slowly growing
painless mass in labia majora. The lack of symptoms in
the first period and the rapid tendency of spread to the
body justify the poor prognosis of these cases.
Given the varied morphologic features and immuno-
phenotypic heterogeneity of the present case, PES can
potentially be mistaken for other epithelioid malig-
nancy. Immunohistochemical studies on PES show im-
munoreactivity for vimentin, cytokeratin, and ephitelial
membrane antingen (MEA). S 100 and CD31 are negative,
while desmin and CD34 are positive in some cases [18].
Langerhans cell sarcoma (LCS) or mammary sarcoma
(MS) may be similar to PES but immunohistochemistry,
in the LCS the tumour cells are positive for CD1a, S-100
protein and langerin strongly and diffusely [29], while in
MS CD10 and vimentin are positive diffusely whereas epi-
thelial markers and other myoepithelial or myogenic
markers were all negative [30]. In Prostatic stromal sar-
coma (PSS) unlike the PES, immunohistochemically, the
tumour cells are widely positive for vimentin, CD56,
CD99 and focally positive for synaptophysin, CD10, pro-
gesterone receptor, desmin and CD34, but negative for
EMA, cytokeratin, estrogen receptor, S-100 and myoglo-
bin [31]. Epithelioid malignant peripheral nerve sheath
tumors (MPNSTs) might be positive for cytokeratin and
EMA occasionally, but about 80% of cases of MPNST
show diffuse and strong reactivity for S-100 protein
[32]. Similarly, malignant melanomas are typically strongly
immunoreactive for S-100 protein and gp100 protein
(HMB-45). A particular differential diagnosis between
proximal epithelioid sarcoma and malignant rhabdoid
tumor (MRT) could be arduous but of extremely import-
ance. The distinguishing between them could be reached
using an innovative molecular marker, INI1, as suggested
by some authors. In fact the tumors from the two different
categories lack the INI1 gene product. Nevertheless, the
literature suggests that other selected genetic differences
between the 2 lesions, and the more rapid and aggressive
course of MRT distinguish these tumor types as separ-
ate clinicopathologic entities [26]. Even the epithelioid
angiosarcoma may be similar to the PES, in fact
immunohistochemically the tumor is positive for the
pan-cytokeratin, p63, cytokeratin18, Vimentin and
vascular markers CD31, and is negative for CD34,
cytokeratin5/6, cytokeratin7, cytokeratin20, CD68,
CD30, S-100, HMB45, desmin, α-SMA and CD45 [33].
Epithelioid sarcomas are easily distinguished from
leiomyosarcomas by their lacking a representative area
of a leiomyosarcoma, showing fascicles of elongated
tumor cells with blunt-ended "cigar-shaped" atypical
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and SMA [34].
The distinction between proximal-type epithelioid sar-
coma and undifferentiated carcinoma is probably the most
difficult consideration [35]. The occurrence of tumors in
the subcutis or deep soft tissues without any connection
with the overlying epidermis or cutaneous adnexa, the
absence of histologic features of squamous or glandular
differentiation, and presence of CD34 reactivity in about
half of the cases favor the diagnosis of epithelioid sarcoma
over undifferentiated carcinoma. The latter are negative
for CD34 in most cases [36].
In conclusion the PES of the vulva is rare, radical sur-
gery with lymphadenectomy and adjuvant therapy seems
not to guarantee better DFS and OS and early detection
plays a crucial role. For this reason these cases should be
directed to referral centers of oncology.
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